Trial Profile
Safety and Immunogenicity Among Adults of Fluzone Quadrivalent, Fluzone Intradermal, and Fluzone High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 15 Oct 2014 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov record.
- 10 Oct 2014 New trial record